Aort hastalıklarında torakal endovasküler anevrizma onarımlarımızın erken, orta ve geç dönem sonuçları

---

Thesis Type: Expertise In Medicine

Institution Of The Thesis: Ankara University, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Turkey

Approval Date: 2018

Thesis Language: Turkish

Student: GÖKAY DENİZ

Supervisor: SADIK ERYILMAZ

Open Archive Collection: AVESIS Open Access Collection

Abstract:

Thoracic endovascular aortic aneurysm repair (TEVAR) is a technique that includes less mortality and morbidity compared to open surgery in thoracic aortic pathologies. Over the years, endovascular repair has become more popular over the years, with short hospitalization, rapid recovery, shorter treatment times and fewer treatment options. However, further research is needed for the long-term results of TEVAR. In this study, we evaluated the 10-year long-term results of our TEVAR roundabouts performed in our clinic between March 2005 and March 2018. Followup was routinely performed 1 month, 6 months, 1 year, 2 years, 5 years and 10 years postoperatively, and mortality was examined in terms of major complications over the years. The number of men in the study is 3 times the number of women. Etiologically, 51 aneurysms (52%), 1 type A, 27 type B total 28 dissection (29%), 5 penetrating aortic ulcers (5%), 5 intramural hematoma (5%), 6 following a traffic accident TEVAR procedure was performed for transection (6%), 1 aortic coarctation (1%) and 1 iatrogenic aortic injury (1%). Overall mortality at 10-year follow-up. In 20 patients, TEVAR-associated mortality was 8 in postoperative first month and 13 in 10 years follow-up. The most common cause of mortality is rupture in 4 patients. In 15 patients, endoleak was seen and 16 patients were re-intervened. Type 1 endoleak was the most common type of endoleaks (n = 11). The most frequent reintervention was reTEVAR seen in 11 patients. Mortality increases as graft diameter and graft length increase. COPD is the most important comorbid disease that increases the risk of 10 years of TEVAR mortality by 4.7 times. Three patients underwent debranching surgery, 27 patients underwent caroticosubclavian bypass surgery and 30 patients underwent hybrid operation with TEVAR. In our TEVAR procedures, our long-term mortality is 4 patients and our results are consistent with the literature. Key Words: Endoleak, Hybrid operation, Long term results, TEVAR, Thoracic aortic diseases